Cargando…
Clinical Application of Plasma Neurofilament Light Chain in a Memory Clinic: A Pilot Study
BACKGROUND AND PURPOSE: Neurofilament light chain (NfL) has been considered as a biomarker for neurodegenerative diseases including Alzheimer’s disease (AD). We measured plasma NfL levels in older adults with cognitive complaints and evaluated their clinical usefulness in AD. METHODS: Plasma levels...
Autor principal: | Shim, YongSoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Dementia Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085534/ https://www.ncbi.nlm.nih.gov/pubmed/35585907 http://dx.doi.org/10.12779/dnd.2022.21.2.59 |
Ejemplares similares
-
Blood neurofilament light chain at the doorstep of clinical application
por: Leppert, David, et al.
Publicado: (2019) -
Plasma Neurofilament Light Chain and Clinical Diagnosis in Frontotemporal Dementia Syndromes
por: Ooi, Suyi, et al.
Publicado: (2022) -
Neurofilament light chain levels in MS: At the doorstep of clinical application
por: Dalmau, Josep
Publicado: (2019) -
Comparing Neurofilament Light Chain Levels in Serum and Plasma
por: Kwon, Hyuk Sung, et al.
Publicado: (2023) -
Plasma neurofilament light chain protein is not increased in forensic psychiatric populations: a pilot study
por: Fernqvist, Anja, et al.
Publicado: (2023)